Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 4/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | INSR | P06213 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | CYBB | P04839 | 1/20 | 0.34 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21609721 | 1.00 | SIGMAR1 (0.45) | SIGMAR1CYP1A2KDM1ABCHEHDAC3 | |
| SCHEMBL21267711 | 0.77 | SIGMAR1 (0.47) | SIGMAR1CYP1A2BCHECHRM1HTR2A | |
| SCHEMBL29293075 | 0.76 | CHRM1 (0.45) | SIGMAR1KMT2AMEN1CHRM1HTR2A | |
| SCHEMBL11209572 | 0.73 | BCHE (0.46) | SIGMAR1BCHEACHE | |
| SCHEMBL17195664 | 0.72 | MAPT (0.56) | CYP1A2HDAC3HDAC1HDAC2NPC1 | |
| SCHEMBL26800298 | 0.72 | MEN1 (0.46) | KDM1AKMT2ANPC1RAB9AMEN1 | |
| SCHEMBL7724186 | 0.71 | SIGMAR1 (0.40) | SIGMAR1BCHEKMT2AACHE | |
| SCHEMBL28725607 | 0.71 | SIGMAR1 (0.43) | SIGMAR1CYP1A2BCHEKMT2ANPC1 | |
| SCHEMBL23699996 | 0.71 | LSS (0.39) | KDM1AKMT2AMEN1 | |
| SCHEMBL16358422 | 0.71 | MAPT (0.50) | CYP1A2HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200255457-A1 | PROCESS FOR THE REMOVAL AND RETURN OF A CATALYST TO A LIQUID PHASE MEDIUM | PHOSPHONICS LTD (GB) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255457-A1 | PROCESS FOR THE REMOVAL AND RETURN OF A CATALYST TO A LIQUID PHASE MEDIUM | MSR1, NOC2L, GFRA2 | SIGMAR1 630/4885CYP1A2 1399/4885KDM1A 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.